CrushSCI.com
Journal Selection & Manuscript Polishing Services
BONE MARROW TRANSPLANTATION 临时占位封面 Medicine
Back to journal directory

Review Cycle Records

BONE MARROW TRANSPLANTATION

Springer SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
128.2Average days
127Median days
24Fastest days
219Longest days
2892025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

219 days

Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia

AuthorsLoïc Guillerault; Paul Saultier; Carine Domenech; Stéphane Ducassou; Virginie Gandemer; Sandrine Visentin; Cécile Renard; Catherine Paillard; Marilyne Poiree; Aurélie Phulpin; Justyna Kanold; Marie-Dominique Tabone; Jean-Hugues Dalle; Laura Olivier; Corinne Armari-Alla; Sandrine Thouvenin; Isabelle Pellier; Pascal Auquier; Julie Berbis; Gérard Michel; Blandine Courbiere

Affiliations1. Department of Gynecology-Obstetric and Reproductive Medicine, AP-HM, Hôpital La Conception, Marseille, France; 2. Department of Pediatric Hematology, Immunology and Oncology, Aix Marseille Univ, APHM, INSERM, INRAe, C2VN, La Timone Children’s Hospital, Marseille, France; 3. Department of Pediatric Hematology and Oncology, IHOP, Hospices Civils de Lyon, Lyon 1 University, Lyon, France; 4. Department of Pediatric Hematology and Oncology, University Hospital of Bordeaux, Bordeaux, France; 5. Department of Pediatric Hematology and Oncology, University Hospital of Rennes, Rennes, France; 6. Department of Pediatric Hematology, Immunology and Oncology, APHM, La Timone Children’s Hospital, Marseille, France; 7. Department of Pediatric Hematology-Oncology, University Hospital, Strasbourg, France; 8. Department of Pediatric Hematology and Oncology, University Hospital L’Archet, Nice, France; 9. Department of Pediatric Hematology and Oncology, Children’s Hospital of Brabois, Vandoeuvre-Les-Nancy, France; 10. Department of Pediatric Hematology and Oncology, CIC Inserm 501, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France; 11. Department of Pediatric Hematology, Immunology and Oncology, Hôpital Armand Trousseau, Paris, France; 12. Department of Hematology and immunology, Hôpital Robert-Debré, GHU APHP-Nord Université Paris-Cité, Paris, France; 13. Department of Pediatric Hematology and Oncology, University Hospital of Toulouse, Toulouse, France; 14. Department of Pediatric Hematology-Oncology, University Hospital of Grenoble, Grenoble, France; 15. Department of Pediatric Onco-hematology, University Hospital of Saint-Etienne, Saint-Etienne, France; 16. Department of Pediatric Hematology, Immunology and Oncology, University Hospital of Angers, Angers, France; 17. Department of Epidemiology and Health Economics, Aix Marseille Univ, APHM, CEReSS, Health Service Research and Quality of Life Center, Equipe labellisée Ligue contre le Cancer, La Timone Hospital, Marseille, France; 18. CEReS Research Unit EA 3279 and Department of Public Health, Hôpital de la Timone, Marseille, France; 19. IMBE, Aix Marseille Univ, Avignon Univ, CNRS, IRD, Marseille, France

Source PDF DOI Publisher page
127 days

Real-world experience with posttransplant maintenance therapy in patients with myeloid neoplasms with active disease before allogeneic hematopoietic cell transplantation

AuthorsHüseyin Sakiz; Raphael Battegay; Beatrice Drexler; Darius Juskevicius; Sabine Gerull; Michele Hoffmann; Roby Mathew; Francesca Matteazzi; Lucas Simeon; Georg Stussi; Jakob R. Passweg; Joerg P. Halter

Affiliations1. Department of Hematology, University Hospital Basel, Basel, Switzerland; 2. Department of Hematology, Cantonal Hospital Aarau, Aarau, Switzerland; 3. Department of Medical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland; 4. Department of Hematology, Luzerner Kantonsspital, Lucerne, Switzerland; 5. Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Source PDF DOI Publisher page
154 days

Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation

AuthorsTakuto Mori; Nobuhiro Hiramoto; Yoshimitsu Shimomura; Masao Ogata; Kaito Harada; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Masahito Tokunaga; Atsushi Wake; Yasufumi Uehara; Toshimitsu Ueki; Masashi Sawa; Satoshi Takahashi; Mamiko Sakata-Yanagimoto; Keisuke Kataoka; Toshiro Kawakita; Noriko Doki; Fumihiko Ishimaru; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone; Kimikazu Yakushijin

Affiliations1. Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan; 2. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 3. Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan; 4. Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan; 5. Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan; 6. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; 7. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan; 8. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; 9. Department of Hematology, Imamura General Hospital, Kagoshima, Japan; 10. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Kawasaki, Japan; 11. Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan; 12. Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan; 13. Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; 14. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 15. Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; 16. Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; 17. Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan; 18. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; 19. Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; 20. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 21. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; 22. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; 23. Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan; 24. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; 25. Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan

Source PDF DOI Publisher page
117 days

Use of an unrelated cord blood unit as an emergency rescue graft after last-minute donor collection cancellation

AuthorsIrene Donnini; Sergio Querol; Nerea Castillo; Simona Pollichieni; Chiara Nozzoli; Alejandra Martínez-Trillos; Mónica Linares; Michela Santosuosso; Serena Urbani; Jesús Fernández-Sojo; Nicoletta Sacchi

Affiliations1. Cell Therapy and Transfusion Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 2. Spanish Bone Marrow Donor Registry (REDMO), Josep Carreras Leukaemia Foundation, Barcelona, Spain; 3. Cell Therapy Service and Barcelona Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain; 4. Italian Bone Marrow Donor Registry (IBMDR), Diagnostic and Therapeutic Services Department, E.O. Ospedali Galliera, Genoa, Italy; 5. Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Source PDF DOI Publisher page
24 days

PTCy-based GVHD prophylaxis helps navigate donor selection in secondary AML undergoing alternative donor transplantation

AuthorsPunit Jain

Affiliations1. Department of Hematology & Bone Marrow Transplant, Apollo Hospitals, Navi Mumbai, India

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.